Unlearn.ai
AI-powered digital twins and scientific intelligence for faster, smarter clinical trials
Enterprise·Technical·Powered by Unlearn proprietary AI
Key strengths
AI-generated digital twins for patient outcome forecastingEMA-qualified methodology aligned with FDA guidanceIntegrated platform covering trial planning, monitoring, and analysisAutomated literature and regulatory precedent search (Scout)Measurable reductions in control arm size (~33%) and enrollment time (4+ months)
Enterprise pricing
US
Facts verified against unlearn.ai on
Get alerts when Unlearn.ai changes
Free. We'll email you when pricing, the free tier, API access or open-source status changes.
No ratings yet
Unlearn — Technical Overview
Unlearn is an AI platform that generates digital twins of patients to augment clinical trial design and execution for pharmaceutical and biotech organizations. By modeling individual patient trajectories, Unlearn enables statistically rigorous augmentation of control arms, reducing the required number of enrolled participants without sacrificing trial validity.
Key platform capabilities include:
- Digital twin generation for individual trial participants, applicable across randomized controlled trials (RCTs) and single-arm studies
- Control arm augmentation — reducing control arm size by approximately 33%
- Overall sample size reduction of approximately 20%
- Enrollment acceleration — saving 4+ months of enrollment time
- Integration across the full clinical trial lifecycle: trial design, in-progress monitoring, and post-readout analysis
Alternatives
See all alternatives Alternatives to Unlearn.ai
Is Unlearn.ai yours? Claim the listing & get the badge